Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
Accuracy of a custom physical activity and knee angle measurement sensor system for patients with neuromuscular disorders and gait abnormalities.
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
Gait and six-minute walk performance in persons with multiple sclerosis.
Clarification on neuromuscular conditions in careers article.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
[Vitamin D and multiple sclerosis].
Multiple sclerosis: Sodium channel blocker protects axons in MS models.
Multiple sclerosis: Monotherapy rules.
The co-occurrence of pain and depression in adults with multiple sclerosis.
Danish translation and psychometric testing of the Rivermead Mobility Index.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
How microglia kill neurons.
Structural brain lesions in inflammatory bowel disease.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
HSV1 and 2 Detection in the CSF of Multiple Sclerosis Patients by Real-time PCR.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
The clinico-radiological paradox in multiple sclerosis: novel implications of lesion size.
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
Advances in the management of MS symptoms: real-life evidence.

Pages